Susquehanna International Group, LLP Phathom Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$10.25 - $19.5 $121,975 - $232,050	-11,900 Reduced 39.4%	18,300 $330,000
Q2 2024 Aug 15, 2024	SELL	$8.97 - $12.05 $174,915 - $234,975	-19,500 Reduced 39.24%	30,200 $311,000
Q1 2024 May 07, 2024	BUY	$6.21 - $11.05 $308,637 - $549,185	49,700 New	49,700 $527,000
Q3 2023 Nov 14, 2023	SELL	$10.26 - $15.7 $80,028 - $122,460	-7,800 Reduced 22.94%	26,200 $271,000
Q2 2023 Aug 11, 2023	BUY	$7.28 - $14.32 $247,520 - $486,880	34,000 New	34,000 $486,000

144

73.6M

42.3K

45.7K

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $320M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.